• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Two words to describe Amgen....

























































loony bin -- full of blind visionaries who bought a new, unproven CFO from 3M for millions just prior to heavy layoffs of proven, hard-working, experienced professionals and ironically put a psychiatrist in charge of drug safety. shit howdy